Reviva Pharmaceuticals Holdings, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -29.7% | -29.7% | -27.1% |
| FY2022 | -336.7% | -336.7% | -149.3% |
| FY2023 | -686.5% | -686.5% | -165.7% |
| FY2024 | -3,682.0% | -3,682.0% | -193.0% |
| FY2025 | -229.7% | -229.7% | -124.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -29.7% | -29.7% | -27.1% |
| FY2022 | -336.7% | -336.7% | -149.3% |
| FY2023 | -686.5% | -686.5% | -165.7% |
| FY2024 | -3,682.0% | -3,682.0% | -193.0% |
| FY2025 | -229.7% | -229.7% | -124.8% |